Jul 01, 2020
Retina Awarded Agency of the Year by the Association of National Advertisers (ANA)
Jun 16, 2020
$3.27 Billion Retinal Surgery Devices Market Assessment 2020-2026 - COVID-19 Updated
Jun 16, 2020
Global Retinal Surgery Devices Industry (2019 to 2027) - Market Trajectory & Analytics
Jun 09, 2020
U.S. Food & Drug Administration Grants 510(k) Clearance For Vasoptic Medical's Retinal Imaging Device
May 28, 2020
Kodiak Sciences to Present at Upcoming Conferences
May 18, 2020
MacuHealth Congratulates Dr Paul Bernstein and the Bernstein Laboratory for Their Recent Publication in PNAS
May 13, 2020
Optina Diagnostics receives 510(k) clearance from U.S. FDA for its MHRC-C1, permitting hyperspectral imaging of the retina
May 11, 2020
Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference
May 08, 2020
Kodiak Sciences to Host First Quarter 2020 Business Highlights Webcast on May 12, 2020
Apr 15, 2020
Retinal Imaging Device Market to 2027 - Global Analysis and Forecasts by Device Type; End-User; and Geography
Apr 02, 2020
Kodiak Sciences Appoints Charles Bancroft to Board of Directors
Mar 30, 2020
Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device
Mar 16, 2020
Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Mar 12, 2020
Everads Therapy Enters Into Option Agreement With Global Pharma Company to License Everads' Suprachoroidal Delivery System for Retinal Disease Therapies
Mar 04, 2020
Vitamin Science Announces the Release of a Unique Eye Vitamin Formula for Blue Light Protection
Feb 27, 2020
Kodiak Sciences to Present at Upcoming Conferences
Feb 24, 2020
ReNeuron Announces Positive Long-term Data in Retinal Clinical Trial
Feb 05, 2020
Kodiak Sciences Announces Upcoming Presentation of Additional KSI-301 Phase 1b Clinical Study Data at Angiogenesis, Exudation, and Degeneration 2020 Meeting
Jan 27, 2020
Potent affronEYE® Saffron Extract May Lower Risk of Glaucoma
Jan 13, 2020
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)